FDA-approved at-home brain stimulation treatment for depression
Flow Neuroscience develops the world's first FDA-approved at-home tDCS (transcranial direct current stimulation) treatment for Major Depressive Disorder. The Flow FL-100 headset is a non-invasive neuromodulation device used in combination with a behavioral therapy app, providing home-based treatment for patients with moderate to severe MDD. Backed by real-world evidence from over 40,000 users and multiple clinical trials, Flow has received medical certification across Europe and the UK, and FDA approval in the US.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2025
Aug 2021
Nov 2019
Create a free account to see which investors have funded this company.
Create Free Account
Fusion energy company developing clean energy solutions.
operates in the healthcare industry focusing on biotechnology business
Clinical-stage medical technology company developing neural-engineering implants and platforms to...
Vicarious Surgical improves the lives of patients and surgeons by giving access to high quality c...
Digital tools for healthcare providers
Developing an Innovative Endoscopic Outpatient Procedure to Improve Glycemic Control for Type 2 D...
